102 related articles for article (PubMed ID: 29416770)
21. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Coulthard SA; Matheson EC; Hall AG; Hogarth LA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
[TBL] [Abstract][Full Text] [Related]
22. Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy.
Palmieri O; Latiano A; Bossa F; Vecchi M; D'Incà R; Guagnozzi D; Tonelli F; Cucchiara S; Valvano MR; Latiano T; Andriulli A; Annese V
Aliment Pharmacol Ther; 2007 Sep; 26(5):737-45. PubMed ID: 17697207
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
[TBL] [Abstract][Full Text] [Related]
24. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia.
Zimm S; Reaman G; Murphy RF; Poplack DG
Cancer Res; 1986 Mar; 46(3):1495-8. PubMed ID: 2417705
[TBL] [Abstract][Full Text] [Related]
25. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.
Yamashina K; Miller BE; Heppner GH
Cancer Res; 1986 May; 46(5):2396-401. PubMed ID: 3084067
[TBL] [Abstract][Full Text] [Related]
26. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
27. Phorbol ester-induced differentiation of a non-T/non-B human leukemic cell line (REH) to macrophage-like cells.
Srivastava BI; Koga M; Srivastava P
Cancer Res; 1984 Jul; 44(7):3017-21. PubMed ID: 6373000
[TBL] [Abstract][Full Text] [Related]
28. Limited intra-individual variability in hypoxanthine-Guanine phosphoribosyl transferase, thiopurine S-methyl transferase, and xanthine oxidase activity in inflammatory bowel disease patients during 6-thioguanine therapy.
van Asseldonk DP; de Boer NK; Smid K; Mulder CJ; van Bodegraven AA; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):284-90. PubMed ID: 20544508
[TBL] [Abstract][Full Text] [Related]
29. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
Sanderson J; Ansari A; Marinaki T; Duley J
Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
[TBL] [Abstract][Full Text] [Related]
30. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
31. Pseudogene-free amplification of HPRT1 in quantitative reverse transcriptase polymerase chain reaction.
Valadan R; Amjadi O; Tehrani M; Rafiei A; Hedayatizadeh-Omran A; Alizadeh-Navaei R
Anal Biochem; 2015 Sep; 485():46-8. PubMed ID: 26050630
[TBL] [Abstract][Full Text] [Related]
32. Role of ubiquitin carboxyl terminal hydrolase in the differentiation of human acute lymphoblastic leukemia cell line, Reh.
Maki A; Mohammad RM; Smith M; Al-Katib A
Differentiation; 1996 Mar; 60(1):59-66. PubMed ID: 8935929
[TBL] [Abstract][Full Text] [Related]
33. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
34. Different somatic and germline HPRT1 mutations promote use of a common, cryptic intron 1 splice site. Mutation in brief no. 259. Online.
Colgin LM; Hackmann AF; Monnat RJ
Hum Mutat; 1999; 14(1):92. PubMed ID: 10447274
[TBL] [Abstract][Full Text] [Related]
35. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.
Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA
Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030
[TBL] [Abstract][Full Text] [Related]
36. [Macrophage-mediated induction of drug-resistance variants in a mouse mammary tumor cell line].
Yamashina K
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):568-75. PubMed ID: 3758918
[TBL] [Abstract][Full Text] [Related]
37. Methylsulfonylmethane inhibits cortisol-induced stress through p53-mediated
Sp N; Kang DY; Kim DH; Lee HG; Park YM; Kim IH; Lee HK; Cho BW; Jang KJ; Yang YM
Exp Ther Med; 2020 Jan; 19(1):214-222. PubMed ID: 31853292
[TBL] [Abstract][Full Text] [Related]
38. Determination of inosine 5'-monophosphate dehydrogenase activity in red blood cells of thiopurine-treated patients using HPLC.
Beringer A; Citterio-Quentin A; Otero RO; Gustin C; Clarke R; Salvi JP; Boulieu R
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():194-199. PubMed ID: 28110955
[TBL] [Abstract][Full Text] [Related]
39. Different somatic and germline HPRT1 mutations promote use of a common, cryptic intron 1 splice site. Mutations in brief no. 246. Online.
Colgin LM; Hackmann AF; Monnat RJ
Hum Mutat; 1999; 13(6):504-5. PubMed ID: 10408785
[TBL] [Abstract][Full Text] [Related]
40. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
